- Home
- MRSN vs VPG Comparison
MRSN vs VPG Comparison
Compare MRSN & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- VPG
- Stock Information
- Founded
- MRSN 2001
- VPG 2009
- Country
- MRSN United States
- VPG United States
- Employees
- MRSN N/A
- VPG N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- VPG Electrical Products
- Sector
- MRSN Health Care
- VPG Technology
- Exchange
- MRSN Nasdaq
- VPG Nasdaq
- Market Cap
- MRSN 252.0M
- VPG 283.7M
- IPO Year
- MRSN 2017
- VPG N/A
- Fundamental
- Price
- MRSN $1.86
- VPG $24.38
- Analyst Decision
- MRSN Buy
- VPG Hold
- Analyst Count
- MRSN 6
- VPG 1
- Target Price
- MRSN $6.00
- VPG $31.00
- AVG Volume (30 Days)
- MRSN 1.1M
- VPG 134.4K
- Earning Date
- MRSN 11-13-2024
- VPG 11-05-2024
- Dividend Yield
- MRSN N/A
- VPG N/A
- EPS Growth
- MRSN N/A
- VPG N/A
- EPS
- MRSN N/A
- VPG 0.99
- Revenue
- MRSN $34,837,000.00
- VPG $323,397,000.00
- Revenue This Year
- MRSN N/A
- VPG N/A
- Revenue Next Year
- MRSN N/A
- VPG $1.31
- P/E Ratio
- MRSN N/A
- VPG $24.45
- Revenue Growth
- MRSN N/A
- VPG N/A
- 52 Week Low
- MRSN $1.22
- VPG $20.83
- 52 Week High
- MRSN $6.28
- VPG $35.98
- Technical
- Relative Strength Index (RSI)
- MRSN 42.16
- VPG 56.18
- Support Level
- MRSN $1.93
- VPG $23.68
- Resistance Level
- MRSN $2.81
- VPG $25.44
- Average True Range (ATR)
- MRSN 0.24
- VPG 0.87
- MACD
- MRSN -0.05
- VPG 0.09
- Stochastic Oscillator
- MRSN 7.79
- VPG 57.55
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates majority of its revenue from United States.